TAL
PRVL

TIG Advisors LLC’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

TIG Advisors LLC’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-709,282
Closed -$16.4M – 454
2020
Q4 		$16.4M Buy
+709,282
New +$16.4M 0.82% 19